A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.
Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion ...
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
Identify the warning signs of hepatitis before they become serious. From subtle fatigue to more obvious symptoms, recognizing liver inflammation early can save.
Asian News International on MSN3d
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASHShilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the ...
A group of state lawmakers and a Macomb County official want stricter limits than the state proposes for Oakland County's ...
Dr. Lisa Nash, a TCOM graduate, will continue to lead the college toward excellence. Leadership at The University of North ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback